Related Experiment Videos
Acute haemodynamic and metabolic effects of felodipine in congestive heart failure
Insights
Felodipine, a selective calcium antagonist, effectively reduces afterload in patients with congestive heart failure. This improves cardiac function and myocardial oxygen supply, suggesting its potential as a novel treatment.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Congestive heart failure (CHF) is a complex condition characterized by impaired cardiac function.
- Effective management of CHF often involves reducing cardiac afterload.
Purpose of the Study:
- To evaluate felodipine's efficacy as an afterload-reducing agent in patients with congestive heart failure.
- To assess the hemodynamic and metabolic effects of felodipine in this patient population.
Main Methods:
- A study involving 11 patients diagnosed with congestive heart failure.
- Hemodynamic parameters including cardiac index, systemic vascular resistance, and left ventricular pressures were measured.
- Left ventricular dimensions and myocardial oxygen supply/demand were assessed.
Main Results:
- Felodipine significantly reduced systemic vascular resistance and left ventricular end-diastolic pressure.
- Cardiac index increased substantially, indicating improved cardiac output.
- Myocardial oxygen supply to demand ratio improved due to increased coronary sinus flow and decreased consumption.
Conclusions:
- Felodipine demonstrates beneficial hemodynamic and metabolic effects in patients with congestive heart failure.
- Its vascular selectivity suggests potential for expanded clinical use in treating heart failure.
- Further research is warranted to confirm felodipine's role in CHF management.
Abstract:
Felodipine is a new calcium antagonist with a high degree of vascular selectivity. To examine its potential value as an afterload reducing agent in congestive heart failure 11 patients were studied. Substantial increments in cardiac index were associated with a fall in systemic vascular resistance. Left ventricular end diastolic pressure was also significantly reduced. Although left ventricular maximum dP/dt remained unchanged, maximum dP/dt/P increased. Left ventricular unloading was reflected by a reduction in cavity dimensions and a shift in the relation between end systolic pressure and dimension downwards and to the left. The myocardial oxygen supply to demand ratio was also improved: coronary sinus flow increased significantly despite a decline in myocardial oxygen consumption. These beneficial haemodynamic and metabolic effects suggest that felodipine may extend the clinical application of calcium antagonists to include the treatment of congestive heart failure.